General
Preferred name
LEVMETAMFETAMINE
Synonyms
Levmetanfetamina ()
Levomethamphetamine ()
L-methamphetamine ()
Levmetamfetamine cii ()
L-Desoxyephedrine ()
(-)-Methamphetamine (hydrochloride) ()
(-)-Methamphetamine (hydrochloride) (CRM) ()
P&D ID
PD071979
CAS
33817-09-3
4846-07-5
826-10-8
Tags
available
drug
Approved by
FDA
Drug Status
approved
investigational
Max Phase
2.0
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
PHARMACODYNAMICS Levomethamphetamine increases norepinephrine release resulting in increased vasocontriction.
MOA Levomethamphetamine crosses the blood-brain-barrier and acts as a TAAR1 agonist,[3] functioning as a selective norepinephrine releasing agent in the central nervous system,
INDICATION Used over-the-counter for nasal congestion.
Compound Sets
6
Cayman Chemical Bioactives
ChEMBL Drugs
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
External IDs
51
Properties
(calculated by RDKit )
Molecular Weight
149.12
Hydrogen Bond Acceptors
1
Hydrogen Bond Donors
1
Rotatable Bonds
3
Ring Count
1
Aromatic Ring Count
1
cLogP
1.84
TPSA
12.03
Fraction CSP3
0.4
Chiral centers
1.0
Largest ring
6.0
QED
0.69
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Source data